Literature DB >> 20305496

Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis.

Amy Sun1, Lewis Hou, Tiffany Prugpichailers, Jason Dunkel, Maziyar A Kalani, Xiaoyuan Chen, M Yashar S Kalani, Victor Tse.   

Abstract

OBJECTIVE: Bioluminescence imaging (BLI) is emerging as a cost-effective, high-throughput, noninvasive, and sensitive imaging modality to monitor cell growth and trafficking. We describe the use of dynamic BLI as a noninvasive method of assessing vessel permeability during brain tumor growth.
METHODS: With the use of stereotactic technique, 10 firefly luciferase-transfected GL26 mouse glioblastoma multiforme cells were injected into the brains of C57BL/6 mice (n = 80). After intraperitoneal injection of D-luciferin (150 mg/kg), serial dynamic BLI was performed at 1-minute intervals (30 seconds exposure) every 2 to 3 days until death of the animals. The maximum intensity was used as an indirect measurement of tumor growth. The adjusted slope of initial intensity (I90/Im) was used as a proxy to monitor the flow rate of blood into the vascular tree. Using a modified Evans blue perfusion protocol, we calculated the relative permeability of the vascular tree at various time points.
RESULTS: Daily maximum intensity correlated strongly with tumor volume. At postinjection day 23, histology and BLI demonstrated an exponential growth of the tumor mass. Slopes were calculated to reflect the flow in the vessels feeding the tumor (adjusted slope = I90/Im). The increase in BLI intensity was correlated with a decrease in adjusted slope, reflecting a decrease in the rate of blood flow as tumor volume increased (y = 93.8e-0.49, R2 = 0.63). Examination of calculated slopes revealed a peak in permeability around postinjection day 20 (n = 42, P < .02 by 1-way analysis of variance) and showed a downward trend in relation to both postinjection day and maximum intensity observed; as angiogenesis progressed, tumor vessel caliber increased dramatically, resulting in sluggish but increased flow. This trend was correlated with Evans blue histology, revealing an increase in Evans blue dye uptake into the tumor, as slope calculated by BLI increases.
CONCLUSION: Dynamic BLI is a practical, noninvasive technique that can semiquantitatively monitor changes in vascular permeability and therefore facilitate the study of tumor angiogenesis in animal models of disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305496      PMCID: PMC3632432          DOI: 10.1227/01.NEU.0000367452.37534.B1

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

Review 1.  Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability.

Authors:  G Zaharchuk
Journal:  AJNR Am J Neuroradiol       Date:  2007 Nov-Dec       Impact factor: 3.825

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Tumor angiogenesis.

Authors:  A I Holleb; J Folkman
Journal:  CA Cancer J Clin       Date:  1972 Jul-Aug       Impact factor: 508.702

4.  Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans blue, and histology: a comparative study.

Authors:  S S Prabhu; W C Broaddus; C Oveissi; S S Berr; G T Gillies
Journal:  IEEE Trans Biomed Eng       Date:  2000-02       Impact factor: 4.538

5.  The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.

Authors:  Anand Veeravagu; Lewis C Hou; Andrew R Hsu; Weibo Cai; Joan M Greve; Xiaoyuan Chen; Victor Tse
Journal:  Neurol Res       Date:  2008-07-25       Impact factor: 2.448

6.  Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume.

Authors:  Giuseppe Petralia; Lorenzo Preda; Gioacchino Giugliano; Barbara A Jereczek-Fossa; Andrea Rocca; Gabriele D'Andrea; Nagaraj Setty Holalkere; Fausto Chiesa; Massimo Bellomi
Journal:  J Comput Assist Tomogr       Date:  2009 Jul-Aug       Impact factor: 1.826

7.  Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.

Authors:  Victor Tse; Yun Yung; Justin G Santarelli; David Juan; Michael Hsiao; Martin Haas; Griffith Harsh; Gerald Silverberg
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

8.  Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice.

Authors:  J S Burgos; M Rosol; R A Moats; V Khankaldyyan; D B Kohn; M D Nelson; W E Laug
Journal:  Biotechniques       Date:  2003-06       Impact factor: 1.993

9.  Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture.

Authors:  Simon R Bababeygy; Samuel H Cheshier; Lewis C Hou; Dominique M O Higgins; Irving L Weissman; Victor C K Tse
Journal:  Stem Cells Dev       Date:  2008-02       Impact factor: 3.272

10.  Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.

Authors:  G Gambarota; W Leenders; C Maass; P Wesseling; B van der Kogel; O van Tellingen; A Heerschap
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

View more
  14 in total

1.  Subcutaneous administration of D-luciferin is an effective alternative to intraperitoneal injection in bioluminescence imaging of xenograft tumors in nude mice.

Authors:  Ashraf A Khalil; Mark J Jameson; William C Broaddus; Theodore D Chung; Sarah E Golding; Seth M Dever; Elisabeth Rosenberg; Kristoffer Valerie
Journal:  ISRN Mol Imaging       Date:  2013

2.  Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.

Authors:  Margaret Folaron; Mukund Seshadri
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 3.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.

Authors:  Sangyub Kim; Yong Zhang; Suni Tang; Chongtao Qin; Deepkamal Karelia; Arati Sharma; Cheng Jiang; Junxuan Lu
Journal:  Prostate       Date:  2019-04-08       Impact factor: 4.104

5.  Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.

Authors:  Wendan Wang; Aashvini Belosay; Xujuan Yang; James A Hartman; Huaxin Song; Urszula T Iwaniec; Russell T Turner; Mona I Churchwell; Daniel R Doerge; William G Helferich
Journal:  Clin Exp Metastasis       Date:  2016-05-21       Impact factor: 5.150

6.  Vascular priming enhances chemotherapeutic efficacy against head and neck cancer.

Authors:  Margaret Folaron; James Kalmuk; Jaimee Lockwood; Costakis Frangou; Jordan Vokes; Steven G Turowski; Mihai Merzianu; Nestor R Rigual; Maureen Sullivan-Nasca; Moni A Kuriakose; Wesley L Hicks; Anurag K Singh; Mukund Seshadri
Journal:  Oral Oncol       Date:  2013-07-23       Impact factor: 5.337

7.  Murine breast cancer mastectomy model that predicts patient outcomes for drug development.

Authors:  Eriko Katsuta; Omar M Rashid; Kazuaki Takabe
Journal:  J Surg Res       Date:  2017-11       Impact factor: 2.192

8.  Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

Authors:  Aurélien Marabelle; Holbrook Kohrt; Idit Sagiv-Barfi; Bahareh Ajami; Robert C Axtell; Gang Zhou; Ranjani Rajapaksa; Michael R Green; James Torchia; Joshua Brody; Richard Luong; Michael D Rosenblum; Lawrence Steinman; Hyam I Levitsky; Victor Tse; Ronald Levy
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

9.  Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts.

Authors:  Li Liu; Haley Beck; Xiaolei Wang; Hsing-Pang Hsieh; Ralph P Mason; Xinli Liu
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

10.  Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; Jay T Myers; Meizhang Li; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Alex Y Huang; Jeremy N Rich
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.